X0306 4 2019-07-22 false 0001271214 Intersect ENT, Inc. XENT 0001620705 West Thomas A. C/O INTERSECT ENT, INC. 1555 ADAMS DRIVE MENLO PARK CA 94025 true true false false President and CEO Common Stock 2019-07-22 4 A false 138455.00 0.00 A 138455.00 D Stock Options (Right to buy) 20.44 2019-07-22 4 A false 97960.00 0.00 A 2029-07-21 Common Stock 97960.00 97960.00 D Stock Options (Right to buy) 20.44 2019-07-22 4 A false 427147.00 0.00 A 2029-07-21 Common Stock 427147.00 427147.00 D Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest in three equal annual installments commencing one year after the grant date. Restricted Stock Units. The vesting commencement date of the option is July 22, 2019. 1/8th of the shares subject to the option shall vest on January 22, 2020 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months. Shares subject to this option shall vest on the third anniversary from the date of grant provided that certain 30-day trailing average stock price (the "Average Closing Price") targets are achieved at any time during the three year period following the date of grant. 33 1/3%, 66 2/3% or 100% of the shares will vest if the Average Closing Price equals or exceeds specific stock price targets. /s/ David A. Lehman, Attorney-in-Fact for Thomas A West 2019-07-24